• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加利福尼亚州处方药监测计划中用于消除患者身份重复记录的记录链接软件比较。

Comparison of record linkage software for deduplicating patient identities in California's Prescription Drug Monitoring Program.

机构信息

Department of Public Health Sciences, University of California, Davis, Davis, California, USA.

Violence Prevention Research Program, Department of Emergency Medicine, University of California, Davis, Sacramento, California, USA.

出版信息

Pharmacoepidemiol Drug Saf. 2024 Jan;33(1):e5699. doi: 10.1002/pds.5699. Epub 2023 Oct 1.

DOI:10.1002/pds.5699
PMID:37779337
Abstract

BACKGROUND

To help prevent overdose deaths involving prescription drugs, accurate linkage of prescription drug monitoring program (PDMP) records for individual patients is essential.

OBJECTIVES

To compare the accuracy of the linkage program used by California's PDMP against various record linkage programs with respect to accuracy in deduplicating patient identities in the PDMP, with implications for identifying high-risk opioid use and outlier behaviors.

RESEARCH DESIGN

We evaluated California's program, Link Plus, LinkSolv, and The Link King on 557 861 PDMP identity records with addresses in two 3-digit zip code areas for patients who filled a controlled substance prescription in 2013. Manual review was performed on a stratified sample of 720 paired records identified as matches by at least one program.

MEASURES

We estimated sensitivity and positive predictive value, and computed PDMP patient alerts for the patient entities identified by each program.

RESULTS

Sensitivity was 95% for LinkSolv and The Link King, 84% for Link Plus, and 73% for California's program; positive predictive value was ≥93% for all programs. The number of patient entities prompting a PDMP alert was similar among the programs for all alerts except multiple provider episodes (obtaining prescriptions from ≥6 prescribers or ≥6 pharmacies in the last 6 months), which were 10.9%, 26.6%, and 16.9% greater using The Link King, Link Plus, and LinkSolv, respectively, compared to California's program.

CONCLUSIONS

PDMPs should assess the accuracy of record linkage algorithms and the impacts of these algorithms on patient safety alerts and develop national best practices for PDMP record linkage.

摘要

背景

为了帮助预防涉及处方药物的用药过量死亡,准确链接个人患者的处方药物监测计划(PDMP)记录至关重要。

目的

针对加利福尼亚州 PDMP 所使用的链接程序,我们比较了其与各种记录链接程序在 PDMP 中重复识别患者身份方面的准确性,这对于识别高风险阿片类药物使用和异常行为具有重要意义。

研究设计

我们评估了加利福尼亚州的 Link Plus、LinkSolv 和 The Link King 这三个程序,这些程序的评估对象为在 2013 年填写受控物质处方的、在两个三位数邮政编码区域有地址的 557861 名 PDMP 身份记录患者。对至少一个程序识别为匹配的 720 对记录的分层样本进行了手动审查。

测量

我们估计了每个程序的敏感性和阳性预测值,并计算了 PDMP 患者实体的识别情况。

结果

LinkSolv 和 The Link King 的敏感性为 95%,Link Plus 为 84%,而加利福尼亚州的程序为 73%;所有程序的阳性预测值均≥93%。对于所有警报,除了多重提供者情节(在过去 6 个月内从≥6 名开方者或≥6 家药店获得处方)之外,各个程序引发 PDMP 警报的患者实体数量相似,而使用 The Link King、Link Plus 和 LinkSolv 分别比加利福尼亚州的程序多 10.9%、26.6%和 16.9%。

结论

PDMP 应评估记录链接算法的准确性以及这些算法对患者安全警报的影响,并为 PDMP 记录链接制定国家最佳实践。

相似文献

1
Comparison of record linkage software for deduplicating patient identities in California's Prescription Drug Monitoring Program.加利福尼亚州处方药监测计划中用于消除患者身份重复记录的记录链接软件比较。
Pharmacoepidemiol Drug Saf. 2024 Jan;33(1):e5699. doi: 10.1002/pds.5699. Epub 2023 Oct 1.
2
Impacts of prescription drug monitoring program policy changes and county opioid safety coalitions on prescribing and overdose outcomes in California, 2015-2018.2015-2018 年加利福尼亚州处方药物监测计划政策变化和县级阿片类药物安全联盟对处方和过量用药结果的影响。
Prev Med. 2021 Dec;153:106861. doi: 10.1016/j.ypmed.2021.106861. Epub 2021 Oct 20.
3
Provider Prescription Drug Monitoring Program Utilization and Self-Auditing-A Pilot Study.医疗机构药品监测计划的使用和自我审核——一项试点研究。
J Dr Nurs Pract. 2020 Jul 1;13(2):142-147. doi: 10.1891/JDNP-D-19-00064. Epub 2020 Jul 2.
4
Association of Prescription Drug Monitoring Program Use With Opioid Prescribing and Health Outcomes: A Comparison of Program Users and Nonusers.处方药物监测计划的使用与阿片类药物处方和健康结果的关联:使用者与非使用者的比较。
J Pain. 2018 Feb;19(2):166-177. doi: 10.1016/j.jpain.2017.10.001. Epub 2017 Oct 18.
5
Assessment of Postoperative Opioid Prescriptions Before and After Implementation of a Mandatory Prescription Drug Monitoring Program.评估实施强制性处方药物监测计划前后的术后阿片类药物处方。
JAMA Health Forum. 2021 Oct 1;2(10):e212924. doi: 10.1001/jamahealthforum.2021.2924. eCollection 2021 Oct.
6
Prescription Drug Monitoring Program: Registration and Use by Prescribers and Pharmacists Before and After Legal Mandatory Registration, California, 2010-2017.处方药物监测计划:2010-2017 年加利福尼亚州,在法律强制注册前后,医师和药剂师的注册和使用情况。
Am J Public Health. 2018 Dec;108(12):1669-1674. doi: 10.2105/AJPH.2018.304704. Epub 2018 Oct 25.
7
Past-year Prescription Drug Monitoring Program Opioid Prescriptions and Self-reported Opioid Use in an Emergency Department Population With Opioid Use Disorder.过去一年的处方药物监测计划阿片类药物处方和在有阿片类药物使用障碍的急诊科人群中自我报告的阿片类药物使用情况。
Acad Emerg Med. 2018 May;25(5):508-516. doi: 10.1111/acem.13352. Epub 2017 Dec 26.
8
Prescription drug monitoring program design and function: A qualitative analysis.处方药监测项目的设计与功能:一项定性分析
Drug Alcohol Depend. 2017 Nov 1;180:395-400. doi: 10.1016/j.drugalcdep.2017.08.040. Epub 2017 Sep 28.
9
Disclosure of Use and Abuse of Controlled Substances Among Psychiatric Outpatients.精神科门诊患者中受控物质使用与滥用情况的披露
J Psychiatr Pract. 2015 Nov;21(6):412-8. doi: 10.1097/PRA.0000000000000104.
10
Mandatory Review of Prescription Drug Monitoring Program Before Issuance of a Controlled Substance Results in Overall Reduction of Prescriptions Including Opioids and Benzodiazepines.在发放受控物质之前,对处方药物监测计划进行强制性审查,可全面减少包括阿片类药物和苯二氮䓬类药物在内的处方数量。
Pain Physician. 2020 Jun;23(3):299-304.